FOR INNOVATORS

Cancer breakthroughs need capital

between the lab and the patient.

If you’re advancing an early-stage oncology innovation and looking for a partner who understands the path from research to patient — start a conversation.

WHO WE FUND

We invest in pre-seed to Series A oncology companies across three focus areas: therapies & management, diagnostics & monitoring, and prevention & enabling technology.

We’re not a typical venture investor. Our 10,000+ member community of physicians, researchers, and industry professionals serves as a sourcing and evaluation network. When we invest, we bring expertise — not just capital — to help you navigate the path from startup to growth stage.

APPLY FOR FUNDING

If your company fits, complete a profile below for review by our Screening Committee. We respond to every submission.